Latest:
Dr Giles on the Importance of Shared Decision Making When Managing GU Cancers
Rachel Giles, MD, PhD, discusses the importance of incorporating shared decision making in the treatment of patients with genitourinary cancers.
- Advertise
- About OncLive
- Editorial Board
- MJH Life Sciences brands
- Contact Us
- Privacy
- Terms & Conditions
- Do Not Sell My Information
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
© 2025 MJH Life Sciences™ and OncLive - Clinical Oncology News, Cancer Expert Insights. All rights reserved.
Authors
Jasmine M. Zain, MD
Latest:
Dr. Jasmine Zain: Challenges in T-Cell Lymphoma Treatment
Jasmine Zain, MD, director of the T-cell Lymphoma Program, professor of hematology and hematopoietic stem cell transplantation, of City of Hope National Medical Center, discusses the challenges of treatment for patients with T-cell lymphoma.
Martha K. Terris, MD, FACS
Martha K. Terris, MD, FACS,is Professor and Chair of the Department of Urology, holding the Witherington Distinguished Chair in Urology at the Medical College of Georgia at Augusta University.
Latest:
Distinct Risk Factors for Bladder Cancer in Women Necessitate Diligent Early Detection Strategies: With Martha K. Terris, MD, FACS
Dr Terris discusses how the early diagnosis of bladder cancer presents a challenge, particularly in female patients, who are frequently diagnosed later.
Victoria Johnson
Latest:
FDA Panel Gives Beti-Cel Unanimous Support of Benefit in β-thalassemia
The FDA’s Cellular, Tissue, and Gene Therapies Advisory Committee voted unanimously in favor of the benefit of betibeglogene autotemcel for the treatment of transfusion-dependent β-thalassemia in adult and pediatric patients with a non–β0/β0 genotype.
Benjamin V. Stone, MD
Latest:
Dr Stone on the Investigation of Limited English Proficiency and PSA Screening Rates in Prostate Cancer
Benjamin V. Stone, MD, discusses clinical implications derived from a retrospective study on the effect of limited English proficiency on prostate-specific antigen screening rates in American men with prostate cancer, as well as the need to improve equitable access to PSA screening across academic and community centers.
Jorge Nieva, MD
Jorge Nieva, MD, is an associate professor of Clinical Medicine at the Keck School of Medicine of the University of Southern California
Latest:
Dr Nieva on the Role of ADCs in the NSCLC Treatment Paradigm
Jorge Nieva, MD, discusses the current role and the effect antibody-drug conjugates have on the lung cancer treatment paradigm.
Adrián Mosquera Orgueira, MD, PhD,
Adrián Mosquera Orgueira, MD, PhD, is a specialist in Hematology and Hemotherapy and lead researcher of the Computational and Genomic Hematology Group at the Health Research Institute of Santiago de Compostela.
Latest:
Dr Mosquera Orgueira on the Development of a Machine Learning–Based Prognostic Model for Risk Stratification in Myelofibrosis
Thomas Bachelot, MD, PhD
Latest:
Dr. Bachelot on the Role of Tucatinib in HER2+ Breast Cancer With CNS Metastases
Thomas Bachelot, MD, PhD, discusses the role of the combination of tucatinib plus trastuzumab and capecitabine in patients with HER2-positive breast cancer who have central nervous system metastases.